# Saxenda (liraglutide) — safety & injury context

> Clinical summary and reported injury patterns. Not medical advice.

**Canonical URL:** https://drugsmonitor.com/drug-info/saxenda-liraglutide-lawsuit
**Related case:** https://drugsmonitor.com/case/saxenda-liraglutide-lawsuit
**Last updated:** 2026-06-11

## Clinical context

Liraglutide (Saxenda) is a GLP-1-class therapy; plaintiffs group gastrointestinal and related injury theories with broader GLP-1 litigation themes.

## Litigation context

Often analyzed alongside MDL No. 3094 themes; confirm how your court treats product-specific defenses.

---

*Discuss symptoms and treatment with a licensed clinician.*